Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by DeathPoolon Nov 10, 2016 7:28pm
136 Views
Post# 25447434

SEDI Disclosure -Chairman Sold 530,000 Day After Q3 Call

SEDI Disclosure -Chairman Sold 530,000 Day After Q3 Call
Insider name: Kupinsky, Jordan  
Insider's Relationship to Issuer: 4 - Director of Issuer  
Ceased to be Insider: Not applicable  
Security designation: Common Shares Concordia International Corp  
        2910834 2016-11-08 2016-11-09 Indirect Ownership : 
Pride Partnership		 10 - Acquisition or disposition in the public market -530,000 2.4210   100,432                
   
                                         

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities